China's Sinobioway Biomedicine says it will invest nearly $500M on massive biologics site
admin 14th May 2018 Uncategorised 0Betting heavily on a less-regulated CMO market, a Chinese company intends to build a massive biologics plant over the next several years to tap into what it predicts will be the country’s rapid move to cell-based drugs.
More: China's Sinobioway Biomedicine says it will invest nearly 0M on massive biologics site
Source: fierce